Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy

Pulmatrix Revenue 2014-2018 | PULM

Pulmatrix annual/quarterly revenue history and growth rate from 2014 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Pulmatrix revenue for the quarter ending June 30, 2018 was $0.000B, a NAN% increase year-over-year.
  • Pulmatrix revenue for the twelve months ending June 30, 2018 was $0.000B, a 172.63% increase year-over-year.
  • Pulmatrix annual revenue for 2017 was $0B, a 59.88% decline from 2016.
  • Pulmatrix annual revenue for 2016 was $0.001B, a 30.47% decline from 2015.
  • Pulmatrix annual revenue for 2015 was $0.001B, a 241.19% increase from 2014.
Pulmatrix Annual Revenue
(Millions of US $)
2017 $0
2016 $1
2015 $1
2014 $0
2014 $0
2013 $0
2013 $0
2012 $0
Pulmatrix Quarterly Revenue
(Millions of US $)
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $1
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.017B $0.000B
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.215B 15.06
Gilead Sciences (GILD) United States $96.150B 10.67
Biogen (BIIB) United States $66.506B 14.10
Celgene (CELG) United States $58.344B 11.65
Illumina (ILMN) United States $47.253B 59.20
Vertex Pharmaceuticals (VRTX) United States $45.720B 104.01
Regeneron Pharmaceuticals (REGN) United States $42.706B 24.01
Alexion Pharmaceuticals (ALXN) United States $28.205B 21.20
BioMarin Pharmaceutical (BMRN) United States $18.437B 0.00
Incyte (INCY) United States $13.698B 460.29
Seattle Genetics (SGEN) United States $11.706B 0.00
Sarepta Therapeutics (SRPT) United States $9.222B 0.00
QIAGEN (QGEN) Netherlands $8.091B 26.45
Alnylam Pharmaceuticals (ALNY) United States $7.911B 0.00
Exact Sciences (EXAS) United States $7.791B 0.00
Bio-Techne Corp (TECH) United States $6.919B 46.28
BeiGene (BGNE) Cayman Islands $6.673B 0.00
Bluebird Bio (BLUE) United States $6.615B 0.00
Alkermes (ALKS) Ireland $6.337B 0.00
Amarin (AMRN) Ireland $5.879B 0.00
Galapagos (GLPG) Belgium $5.385B 0.00
Exelixis (EXEL) United States $4.924B 16.04
Immunomedics (IMMU) United States $4.241B 0.00
Ligand Pharmaceuticals (LGND) United States $4.159B 36.83
GUARDANT HEALTH (GH) United States $3.351B 0.00
Myriad Genetics (MYGN) United States $3.332B 35.39
Array BioPharma (ARRY) United States $3.292B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.219B 0.00
Horizon Pharma Public (HZNP) Ireland $3.181B 18.01
Emergent Biosolutions (EBS) United States $3.086B 24.58
MorphoSys AG Unsponsored ADR (MOR) Germany $3.078B 0.00
Blueprint Medicines (BPMC) United States $3.059B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.940B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.841B 0.00
Ascendis Pharma (ASND) Denmark $2.772B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.695B 0.00
Halozyme Therapeutics (HALO) United States $2.538B 33.83
Repligen (RGEN) United States $2.475B 83.10
Genomic Health (GHDX) United States $2.437B 135.92
China Biologic Products (CBPO) China $2.394B 16.46
Acceleron Pharma (XLRN) United States $2.378B 0.00
Amicus Therapeutics (FOLD) United States $2.324B 0.00
MyoKardia (MYOK) United States $2.232B 0.00
REGENXBIO (RGNX) United States $2.016B 31.67
Medicines (MDCO) United States $2.010B 0.00
Arena Pharmaceuticals (ARNA) United States $2.000B 0.00
Global Blood Therapeutics (GBT) United States $1.986B 0.00
Akcea Therapeutics (AKCA) United States $1.955B 0.00
AnaptysBio (ANAB) United States $1.953B 0.00
Cambrex (CBM) United States $1.888B 15.14
Spark Therapeutics (ONCE) United States $1.874B 0.00
Reata Pharmaceuticals (RETA) United States $1.818B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.795B 0.00
Allakos (ALLK) United States $1.788B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.756B 0.00
Puma Biotechnology (PBYI) United States $1.657B 0.00
Atara Biotherapeutics (ATRA) United States $1.622B 0.00
Aimmune Therapeutics (AIMT) United States $1.620B 0.00
Clovis Oncology (CLVS) United States $1.577B 0.00
Innoviva (INVA) United States $1.570B 10.08
G1 THERAPEUTICS (GTHX) United States $1.567B 0.00
Denali Therapeutics (DNLI) United States $1.561B 0.00
Sangamo Therapeutics (SGMO) United States $1.443B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.435B 0.00
WAVE Life Sciences (WVE) Singapore $1.432B 0.00
Myovant Sciences (MYOV) United Kingdom $1.389B 0.00
Rubius Therapeutics (RUBY) United States $1.357B 0.00
Mirati Therapeutics (MRTX) United States $1.355B 0.00
Editas Medicine (EDIT) United States $1.352B 0.00
Insmed (INSM) United States $1.312B 0.00
IMMURON LTD (IMRN) Australia $1.287B 0.00
Solid Biosciences (SLDB) United States $1.258B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.202B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.187B 2267.00
Momenta Pharmaceuticals (MNTA) United States $1.154B 0.00
NeoGenomics (NEO) United States $1.140B 199.43
Cellectis (CLLS) France $1.122B 0.00
DBV Technologies (DBVT) France $1.087B 0.00
UniQure (QURE) Netherlands $1.047B 0.00
Lion Biotechnologies (IOVA) United States $1.044B 0.00
Audentes Therapeutics (BOLD) United States $1.035B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.033B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.027B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.026B 0.00
Retrophin (RTRX) United States $1.025B 0.00
Intra-Cellular Therapies (ITCI) United States $1.025B 0.00
Intellia Therapeutics (NTLA) United States $1.006B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.961B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.957B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.916B 0.00
Athenex (ATNX) United States $0.903B 0.00
Acorda Therapeutics (ACOR) United States $0.901B 18.78
Revance Therapeutics (RVNC) United States $0.896B 0.00
Aptinyx (APTX) United States $0.883B 0.00
Viking Therapeutics (VKTX) United States $0.876B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.875B 0.00
Coherus BioSciences (CHRS) United States $0.862B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.808B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.790B 0.00
Cara Therapeutics (CARA) United States $0.784B 0.00
Apellis Pharmaceuticals (APLS) United States $0.779B 0.00
InflaRx (IFRX) Germany $0.775B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.767B 0.00
Heska (HSKA) United States $0.750B 64.57
Novavax (NVAX) United States $0.746B 0.00
CytomX Therapeutics (CTMX) United States $0.740B 0.00
Fate Therapeutics (FATE) United States $0.736B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.727B 0.00
Dynavax Technologies (DVAX) United States $0.712B 0.00
Epizyme (EPZM) United States $0.696B 0.00
AVROBIO (AVRO) United States $0.687B 0.00
Mesoblast (MESO) Australia $0.664B 0.00
ANI Pharmaceuticals (ANIP) United States $0.662B 13.10
AC Immune SA (ACIU) Switzerland $0.634B 0.00
ObsEva SA (OBSV) Switzerland $0.613B 0.00
Anika Therapeutics (ANIK) United States $0.595B 25.04
Kura Oncology (KURA) United States $0.591B 0.00
UROGEN PHARMA (URGN) Israel $0.581B 0.00
MiMedx (MDXG) United States $0.575B 24.67
Arcus Biosciences (RCUS) United States $0.551B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.547B 0.00
RA PHARMCTL INC (RARX) United States $0.531B 0.00
Aduro Biotech (ADRO) United States $0.514B 0.00
Principia Biopharma (PRNB) United States $0.507B 0.00
Vericel (VCEL) United States $0.507B 0.00
Five Prime Therapeutics (FPRX) United States $0.507B 0.00
Inovio Pharmaceuticals (INO) United States $0.505B 0.00
ARVINAS INC (ARVN) United States $0.497B 0.00
UNITY Biotechnology (UBX) $0.496B 0.00
Prothena (PRTA) Ireland $0.489B 0.00
Scholar Rock Holding (SRRK) United States $0.487B 0.00
Kezar Life Sciences (KZR) United States $0.480B 0.00
Stemline Therapeutics (STML) United States $0.479B 0.00
Senesco Technologies (ELOX) United States $0.471B 0.00
Abeona Therapeutics (ABEO) United States $0.466B 0.00
MediciNova (MNOV) United States $0.451B 0.00
GRITSTONE ONCLG (GRTS) United States $0.447B 0.00
BeyondSpring (BYSI) United States $0.445B 0.00
Kindred Biosciences (KIN) United States $0.442B 0.00
Verastem (VSTM) United States $0.431B 0.00
Zealand Pharma (ZEAL) Denmark $0.428B 0.00
Cytokineticsorporated (CYTK) United States $0.425B 0.00
Liquidia Technologies (LQDA) United States $0.424B 0.00
Zymeworks (ZYME) Canada $0.423B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.421B 0.00
Sorrento Therapeutics (SRNE) United States $0.416B 71.20
Sinovac Biotech (SVA) China $0.411B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.387B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.383B 0.00
Replimune (REPL) United States $0.382B 0.00
Proteostasis Therapeutics (PTI) United States $0.380B 0.00
MeiraGTx Holdings (MGTX) United States $0.375B 0.00
PDL BioPharma (PDLI) United States $0.372B 5.22
UROVANT SCIENCS (UROV) United States $0.366B 0.00
KODIAK SCIENCES (KOD) United States $0.356B 0.00
Osiris Therapeutics (OSIR) United States $0.354B 0.00
Eidos Therapeutics (EIDX) United States $0.348B 0.00
Albireo Pharma (ALBO) United States $0.339B 0.00
ResTORbio (TORC) United States $0.339B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.339B 0.00
Selecta Biosciences (SELB) United States $0.339B 0.00
SUTRO BIOPHARMA (STRO) United States $0.332B 0.00
Magenta Therapeutics (MGTA) United States $0.325B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.321B 0.00
Evelo Biosciences (EVLO) United States $0.317B 0.00
Kala Pharmaceuticals (KALA) United States $0.317B 0.00
Geron (GERN) United States $0.314B 0.00
MannKind (MNKD) United States $0.314B 0.00
Kadmon Holdings (KDMN) United States $0.310B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.307B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.301B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.298B 0.00
Adverum Biotechnologies (ADVM) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Unum Therapeutics (UMRX) United States $0.293B 0.00
Athersys (ATHX) United States $0.291B 0.00
Celcuity (CELC) United States $0.291B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.286B 0.00
Axovant Sciences (AXON) United Kingdom $0.286B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.259B 0.00
Celyad SA (CYAD) Belgium $0.257B 0.00
BioTime (BTX) United States $0.256B 0.00
TOCAGEN INC (TOCA) United States $0.253B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Syros Pharmaceuticals (SYRS) United States $0.245B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.238B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.237B 0.00
Synlogic (SYBX) United States $0.235B 0.00
Kamada (KMDA) Israel $0.232B 17.97
Idera Pharmaceuticals (IDRA) United States $0.231B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.229B 0.00
Krystal Biotech (KRYS) United States $0.227B 0.00
Agenus (AGEN) United States $0.227B 0.00
NantKwest (NK) United States $0.219B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.219B 0.00
BioDelivery Sciences (BDSI) United States $0.219B 0.00
Allena Pharmaceuticals (ALNA) United States $0.218B 0.00
Protagonist Therapeutics (PTGX) United States $0.212B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.207B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
Compugen (CGEN) Israel $0.195B 0.00
Mersana Therapeutics (MRSN) United States $0.192B 0.00
Palatin Technologies (PTN) United States $0.187B 7.71
Spring Bank Pharmaceuticals (SBPH) United States $0.184B 0.00
Constellation Pharmaceuticals (CNST) United States $0.183B 0.00
Cerecor (CERC) United States $0.182B 18.63
Eiger BioPharmaceuticals (EIGR) United States $0.171B 0.00
Clearside Biomedical (CLSD) United States $0.171B 0.00
Intec Pharma (NTEC) Israel $0.169B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.169B 0.00
Cohbar (CWBR) United States $0.165B 0.00
Enzo Biochem (ENZ) United States $0.162B 0.00
PSivida (EYPT) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
Spero Therapeutics (SPRO) United States $0.155B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.154B 0.00
Signal Genetics (MGEN) United States $0.150B 0.00
OVID THERAPEUTC (OVID) United States $0.145B 0.00
Pfenex (PFNX) United States $0.142B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Cue Biopharma (CUE) United States $0.141B 0.00
Menlo Therapeutics (MNLO) United States $0.138B 0.00
VBI Vaccines (VBIV) United States $0.136B 0.00
Pluristem Therapeutics (PSTI) Israel $0.134B 0.00
Monster Digital (INNT) United States $0.134B 0.00
Mustang Bio (MBIO) United States $0.132B 0.00
XBiotech (XBIT) United States $0.130B 0.00
Eleven Biotherapeutics (SESN) United States $0.127B 0.00
Motif Bio Plc (MTFB) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.118B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
ITUS (ANIX) United States $0.117B 0.00
VTv Therapeutics (VTVT) United States $0.116B 0.00
XOMA (XOMA) United States $0.115B 12.13
Provention Bio (PRVB) United States $0.115B 0.00
Anavex Life Sciences (AVXL) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.110B 0.00
Axsome Therapeutics (AXSM) United States $0.108B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.103B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Cel-Sci (CVM) United States $0.102B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.100B 0.00
BioXcel Therapeutics (BTAI) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
Neothetics (EVFM) United States $0.098B 0.00
Aptevo Therapeutics (APVO) United States $0.097B 0.00
Orgenesis (ORGS) United States $0.096B 0.00
VolitionRX (VNRX) Singapore $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.094B 0.00
ScPharmaceuticals (SCPH) United States $0.093B 0.00
Prima BioMed (IMMP) Australia $0.092B 0.00
Checkpoint Therapeutics (CKPT) United States $0.092B 0.00
Chiasma (CHMA) United States $0.090B 0.00
Cocrystal Pharma (COCP) United States $0.086B 0.00
OncoSec Medical (ONCS) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.084B 0.55
Protalix BioTherapeutics (PLX) Israel $0.084B 0.00
Vaccinex (VCNX) United States $0.080B 0.00
NewLink Genetics (NLNK) United States $0.080B 0.00
Aptose Biosciences (APTO) Canada $0.079B 0.00
Sophiris Bio (SPHS) United States $0.077B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.073B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
BIONANO GENOMIC (BNGO) United States $0.069B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.066B 0.00
Oncobiologics (ONS) United States $0.066B 0.00
Trevena (TRVN) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.058B 0.00
Oncolytics Biotech (ONCY) Canada $0.056B 0.00
Fortress Biotech (FBIO) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.047B 0.00
Celsion (CLSN) United States $0.047B 0.00
VIVUS (VVUS) United States $0.046B 0.00
Caladrius Biosciences (CLBS) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
GTx (GTXI) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.037B 0.00
BioPharmX (BPMX) United States $0.036B 0.00
Advaxis (ADXS) United States $0.036B 0.00
Proteon Therapeutics (PRTO) United States $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Galena Biopharma (SLS) United States $0.035B 0.00
Aileron Therapeutics (ALRN) United States $0.035B 0.00
Moleculin Biotech (MBRX) United States $0.032B 0.00
CytRx (CYTR) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Histogenics (HSGX) United States $0.026B 0.00
Edge Therapeutics (EDGE) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.023B 46.33
Gemphire Therapeutics (GEMP) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Arsanis (ASNS) United States $0.021B 0.00
RestorGenex (DFFN) United States $0.021B 0.00
TrovaGene (TROV) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 6.19
IBio (IBIO) United States $0.015B 0.00
Adial Pharmaceuticals (ADIL) United States $0.014B 0.00
Neuralstem (CUR) United States $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Oragenics (OGEN) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00